These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15948034)

  • 1. St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.
    Hu Z; Yang X; Ho PC; Chan E; Chan SY; Xu C; Li X; Zhu YZ; Duan W; Chen X; Huang M; Yang H; Zhou S
    Pharm Res; 2005 Jun; 22(6):902-14. PubMed ID: 15948034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
    Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
    Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
    Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF
    Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of St. John's wort on irinotecan metabolism.
    Mathijssen RH; Verweij J; de Bruijn P; Loos WJ; Sparreboom A
    J Natl Cancer Inst; 2002 Aug; 94(16):1247-9. PubMed ID: 12189228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):349-60. PubMed ID: 12904895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea.
    Hidaka M; Yamasaki K; Okumura M; Ogikubo T; Iwakiri T; Setoguchi N; Nishida K; Nagai K; Ikenoue T; Arimori K
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):321-8. PubMed ID: 16770581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.
    Yang XX; Hu ZP; Xu AL; Duan W; Zhu YZ; Huang M; Sheu FS; Zhang Q; Bian JS; Chan E; Li X; Wang JC; Zhou SF
    J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of breast cancer resistance protein inhibitors and pharmaceutical excipients on decreasing gastrointestinal toxicity of camptothecin analogs.
    Zhang XX; Pan WS; Gan L; Zhu CL; Gan Y
    Acta Pharmacol Sin; 2008 Nov; 29(11):1391-8. PubMed ID: 18954535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
    Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St. John's wort and irinotecan-induced diarrhea.
    Birdsall TC
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):108; author reply 109-10. PubMed ID: 17276473
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers.
    Morimoto T; Kotegawa T; Tsutsumi K; Ohtani Y; Imai H; Nakano S
    J Clin Pharmacol; 2004 Jan; 44(1):95-101. PubMed ID: 14681347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility.
    Capasso R; Borrelli F; Aviello G; Capasso F; Izzo AA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):407-14. PubMed ID: 18172613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pre-treatment with St John's Wort on nephrotoxicity of cisplatin in rats.
    Shibayama Y; Kawachi A; Onimaru S; Tokunaga J; Ikeda R; Nishida K; Kuchiiwa S; Nakagawa S; Takamura N; Motoya T; Takeda Y; Yamada K
    Life Sci; 2007 Jun; 81(2):103-8. PubMed ID: 17543347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction between St John's wort and zolpidem in healthy subjects.
    Hojo Y; Echizenya M; Ohkubo T; Shimizu T
    J Clin Pharm Ther; 2011 Dec; 36(6):711-5. PubMed ID: 21058968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
    Allegrini G; Di Paolo A; Cerri E; Cupini S; Amatori F; Masi G; Danesi R; Marcucci L; Bocci G; Del Tacca M; Falcone A
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):585-93. PubMed ID: 16680463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. John's wort significantly increased the systemic exposure and toxicity of methotrexate in rats.
    Yang SY; Juang SH; Tsai SY; Chao PD; Hou YC
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):39-43. PubMed ID: 22699020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T
    Cancer Chemother Pharmacol; 1998; 42(4):280-6. PubMed ID: 9744772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.